Neurotech International Limited (ASX:NTI) has lodged an Appendix 2A application with ASX seeking quotation of 28,100,294 fully paid ordinary shares, issued at AUD $0.014 per security on 17 November 2026, as part of a placement transaction previously announced to the market.
Key Points
- 28,100,294 ordinary fully paid shares applied for quotation at an issue price of AUD $0.01400000 per security, with an issue date of 17 November 2026.
- The securities form part of a transaction previously notified to ASX via an Appendix 3B dated 4 August 2026.
- The company disclosed that 22,500,000 options were also issued on the same date as this Appendix 2A filing, with further issues yet to complete the previously announced transaction.
- Following quotation, total quoted ordinary fully paid shares on issue will stand at 1,644,170,258.
Placement Details and Issue Terms
According to the filing, the 28,100,294 ordinary fully paid securities are being issued for cash consideration in Australian dollars, at an issue price of AUD $0.01400000 per security. The issue date is recorded as 17 November 2026. The securities are described as being issued as part of a placement or other type of issue, referencing the Appendix 3B lodged on 4 August 2026 at 9:27 AM. The filing states that shareholders should refer to resolution 7 of the Notice of Meeting released on 1 October 2026 for further context regarding the securities.
Further Securities Issued Under the Same Transaction
The filing discloses that further issues of securities are yet to take place to complete the transaction referred to in the original Appendix 3B. Specifically, the company stated that the remaining 22,500,000 options were issued on the same date as this Appendix 2A. The filing also noted that, due to ASX form processing, the issued capital figure automatically generated in the form may be incorrect, and that per ASX Appendices released on the same date, the company has issued an additional 42 million options.
Issued Capital Structure Following Quotation
Upon completion of the quotation of the 28,100,294 ordinary shares, the total number of quoted ordinary fully paid securities on issue will be 1,644,170,258. The company's unquoted securities will include 30,000,000 performance rights, 13,000,000 options expiring 13 July 2028 exercisable at $0.02, 6,500,000 options expiring 13 July 2029 exercisable at $0.03, 10,000,000 options expiring 23 December 2027 exercisable at $0.15, 10,000,000 options expiring 23 December 2027 exercisable at $0.10, and 5,000,000 options expiring 24 February 2030 exercisable at $0.16.



Please wait processing your request...